PB2301 ASSESSMENT OF SICKLE PAIN MANAGEMENT IN THE WHITTINGTON HOSPITAL EMERGENCY DEPARTMENT
Authors: K. Orf, L. Akkielah, L. Al Shaman, J. Massie, F. Shah
Journal: HemaSphere (2019)

Background: Sickle cell anaemia (SCA) is an autosomal recessive disorder caused by point mutation of the β‐globin gene, resulting in abnormal forms of hemoglobin that cause increased red blood cell rigidity and hemolysis. It is one of the most common hereditary blood conditions, affecting over 14,000 adults in the UK. One of the manifestations of SCA is vaso‐occlusive crises. These typically cause severe pain that may require emergency department (ED) attendance for pain management, typically with opioids. Those patients in whom pain relief is not well‐controlled are at risk of further complications including acute chest syndrome. The UK National Institute of Clinical Excellence (NICE) published a quality standard in 2014 stating that patients presenting to hospital with an acute painful sickle cell episode should have a pain assessment, a clinical assessment and appropriate analgesia within 30 minutes of presentation. Aims: This study was performed to assess the Whittington Hospital's compliance to national recommendations and try to establish what aspects of care in ED contribute to any delays in management noted. Methods: If a Whittington SCA patient attends ED, an automated email is generated that notifies the haematology team of this. This system was used to identify acute sickle cell presentations to ED. Criteria for inclusion in the study was Whittington SCA patients that presented to ED with acute painful sickle cell crises between August 2017 to January 2018. Patients who received analgesia in the ambulance and patients with no documentation available were excluded. The time of presentation, analgesia prescription and administration for each attendance were noted from ED documentation. Results: A total of 104 ED SCA attendances were included. 41% of patients presenting with an acute painful sickle cell crisis received analgesia during their first 30 minutes in ED. The average wait for analgesia was 47 minutes, with 75% of SCA patients receiving analgesia within 1 hour of arrival. The time taken to triage SCA patients was on average 8 minutes (range 0‐29 minutes). Time from arrival to prescription of pain relief was much more variable with an average wait 40 minutes (range 10 minutes to 2 hours 22 minutes). Patients who frequently attended Whittington ED (defined as 7 or more attendances within the 6 month period studied) had a shorter average wait for analgesia. Analgesia was given 36 minutes after arrival on average for frequent attenders, whereas patients presenting 6 or fewer times had an average wait of 53 minutes. Summary/Conclusion: We are not currently meeting our audit standard for provision of analgesia in the emergency department, and performance appears to have worsened progressively since our earliest available date from 2012 (although methodological differences may have contributed to this). In 2015 49% of patients received analgesia within 30 minutes compared to 41&amp; 2017/18. Most of the delay appears to be due to the time taken for medication to be prescribed, although the time taken to triage the patient and administer the medication was also not insignificant, and often amounted to greater than 30 minutes. It is unclear what is contributing to this delay, although it appears that performance is improved when the patient is a repeat attender and therefore known to the department. Educations sessions with the ED department may improve management of SCA painful crises in ED.